Epizyme, Inc.
EPZMDelisted Aug 12, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001571498
Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.
Holders of 5% or more of EPZM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Epizyme, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Epizyme, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Epizyme, Inc., newest first.
No Schedule 13D or 13G filings on Epizyme, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Epizyme, Inc. shares.
No Form 144 notices for Epizyme, Inc. are on file.